Diagnosing and Managing Schizophrenia: Practical Strategies for the Federal Healthcare Professional
Overview: This activity addresses important issues in the identification, diagnosis, and management of schizophrenia in patients within the federal healthcare system, which includes active-duty servicemembers, Veterans, and others. It is designed to increase the awareness of schizophrenia as a possible diagnosis among other common conditions in this patient population, assist with the development of treatment plans based on current guideline recommendations, and guide the modification of treatment regimens based on patient response, adverse effects, adherence concerns, and other treatment challenges.
Mark Olfson, MD, MPH
William V. Bobo, MD, MPH
Robert A. Rosenheck, MD
Credits available: A maximum of 1.0 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
California Board of Registered Nursing (CBRN)
Accreditation Council for Pharmacy Education (ACPE)
This activity has been approved for AMA PRA Category 1 Credit™.
This activity is supported by
an educational grant from:
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.